You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

The objective of the Ontario Steering Committee for Cancer Drug Programs is to provide evidence based clinical, health research and health economic guidance to the Executive Officer (EO) of Ontario Public Drug Programs (OPDP) on: provincial cancer drug funding policies and decisions, program evaluation and drug-specific studies, and enhancements to cancer drug programs or initiatives in Ontario.

Pages

Subscribe to Cancer Care Ontario RSS